NK cell immunotherapiesrhIL-15National Cancer Institutesolid tumorsrelapsed/refractory solid tumorsNCIcyclophosphamide
…pediatric solid tumors continue to have poor clinical outcomes. NK cell immunotherapies, though promising, face challenges with NK cell expansion, pers…